Review



biotinylated goat anti mouse slpi  (R&D Systems)


Bioz Verified Symbol R&D Systems is a verified supplier
Bioz Manufacturer Symbol R&D Systems manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 94
      Buy from Supplier

    Structured Review

    R&D Systems biotinylated goat anti mouse slpi
    Figure 1 Secretory leukocyte protease inhibitor expression increases in lesional skin of psoriasis patients and in an experimental model of psoriasis. (a) Fluorescence microscopy images of human skin from the donors indicated. Overlay images from 2 healthy and 2 psoriatic donors are shown. Data are representative for at least 4 donors in each group. (b) <t>Slpi</t> gene expression changes during IMQ and Vaseline treatment in C57BL/6 mice. Control = non-treated mice. The data are shown as mean SD from three independent experiments. Dots indicate individual mice. *, P < 0.05; **, P < 0.01; *****, P < 0.00001; ******, P < 0.000001; by Kruskal–Wallis test with multiple com- parisons. (c) Representative images of SLPI protein expression in mouse skin during IMQ treatment. Skin sections were stained for SLPI (green) and DNA (blue). Data are from one experiment and are representative of at least five experiments. Image from SLPI KO mouse is shown as a negative control. Arrowheads in A & C point to SLPI-stained epidermis. Scale bar = 50 lm.
    Biotinylated Goat Anti Mouse Slpi, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 6 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/biotinylated+goat+anti+mouse+slpi/Mouse+SLPI+Biotinylated+Antibody/pm35279880-68-53-57
    Average 94 stars, based on 6 article reviews
    biotinylated goat anti mouse slpi - by Bioz Stars, 2026-09
    94/100 stars

    Images

    1) Product Images from "Secretory leukocyte protease inhibitor regulates nerve reflex-mediated skin barrier function in psoriasis."

    Article Title: Secretory leukocyte protease inhibitor regulates nerve reflex-mediated skin barrier function in psoriasis.

    Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

    doi: 10.1111/jdv.18065

    Figure 1 Secretory leukocyte protease inhibitor expression increases in lesional skin of psoriasis patients and in an experimental model of psoriasis. (a) Fluorescence microscopy images of human skin from the donors indicated. Overlay images from 2 healthy and 2 psoriatic donors are shown. Data are representative for at least 4 donors in each group. (b) Slpi gene expression changes during IMQ and Vaseline treatment in C57BL/6 mice. Control = non-treated mice. The data are shown as mean SD from three independent experiments. Dots indicate individual mice. *, P < 0.05; **, P < 0.01; *****, P < 0.00001; ******, P < 0.000001; by Kruskal–Wallis test with multiple com- parisons. (c) Representative images of SLPI protein expression in mouse skin during IMQ treatment. Skin sections were stained for SLPI (green) and DNA (blue). Data are from one experiment and are representative of at least five experiments. Image from SLPI KO mouse is shown as a negative control. Arrowheads in A & C point to SLPI-stained epidermis. Scale bar = 50 lm.
    Figure Legend Snippet: Figure 1 Secretory leukocyte protease inhibitor expression increases in lesional skin of psoriasis patients and in an experimental model of psoriasis. (a) Fluorescence microscopy images of human skin from the donors indicated. Overlay images from 2 healthy and 2 psoriatic donors are shown. Data are representative for at least 4 donors in each group. (b) Slpi gene expression changes during IMQ and Vaseline treatment in C57BL/6 mice. Control = non-treated mice. The data are shown as mean SD from three independent experiments. Dots indicate individual mice. *, P < 0.05; **, P < 0.01; *****, P < 0.00001; ******, P < 0.000001; by Kruskal–Wallis test with multiple com- parisons. (c) Representative images of SLPI protein expression in mouse skin during IMQ treatment. Skin sections were stained for SLPI (green) and DNA (blue). Data are from one experiment and are representative of at least five experiments. Image from SLPI KO mouse is shown as a negative control. Arrowheads in A & C point to SLPI-stained epidermis. Scale bar = 50 lm.

    Techniques Used: Protease Inhibitor, Expressing, Fluorescence, Microscopy, Gene Expression, Control, Staining, Negative Control

    Figure 2 Secretory leukocyte protease inhibitor affects size of skin lesions and skin barrier function beyond the IMQ-challenged site. The mice indicated were subjected to IMQ-treatment followed by kinetic assessment of the lesion size and skin erythema. (a) The repre- sentative image of female WT and SLPI KO mice from mixed background C57BL/6 9 129/SvJ is shown with the indicated site of treat- ment. (b) Cumulative data (the mean SEM) showing size of lesion. n = 3–10 mice in each group. (c) Cumulative data (the mean SEM) showing skin erythema. (d) WT and SLPI KO C57BL6 males were subjected to IMQ-treatment followed by TEWL measure- ment at the days indicated at the central and lateral skin. The mean SEM is shown. n = at least 10 mice in each group. (e) WT and SLPI KO C57BL6 males were injected with 0.9% NaCl i.d. at the stimulated site prior to IMQ-treatment. TEWL was then measured at the days indicated at the central and lateral skin. The mean SEM is shown. n = at least 7 mice in each group. (f) The lateral skin of WT mice was harvested at the days indicated and subjected to qPCR analysis for Slpi mRNA levels. The data are shown as mean SD from three independent experiments. Dots indicate individual mice. *, P < 0.05; **, P < 0.01; ***, P < 0.001; by ANCOVA followed by Bonferroni post hoc test.
    Figure Legend Snippet: Figure 2 Secretory leukocyte protease inhibitor affects size of skin lesions and skin barrier function beyond the IMQ-challenged site. The mice indicated were subjected to IMQ-treatment followed by kinetic assessment of the lesion size and skin erythema. (a) The repre- sentative image of female WT and SLPI KO mice from mixed background C57BL/6 9 129/SvJ is shown with the indicated site of treat- ment. (b) Cumulative data (the mean SEM) showing size of lesion. n = 3–10 mice in each group. (c) Cumulative data (the mean SEM) showing skin erythema. (d) WT and SLPI KO C57BL6 males were subjected to IMQ-treatment followed by TEWL measure- ment at the days indicated at the central and lateral skin. The mean SEM is shown. n = at least 10 mice in each group. (e) WT and SLPI KO C57BL6 males were injected with 0.9% NaCl i.d. at the stimulated site prior to IMQ-treatment. TEWL was then measured at the days indicated at the central and lateral skin. The mean SEM is shown. n = at least 7 mice in each group. (f) The lateral skin of WT mice was harvested at the days indicated and subjected to qPCR analysis for Slpi mRNA levels. The data are shown as mean SD from three independent experiments. Dots indicate individual mice. *, P < 0.05; **, P < 0.01; ***, P < 0.001; by ANCOVA followed by Bonferroni post hoc test.

    Techniques Used: Protease Inhibitor, Injection

    Figure 3 Secretory leukocyte protease inhibitor deficiency does not affect psoriatic skin thickness and has only a marginal effect on skin inflammation in experimental psoriasis. WT and SLPI KO C57BL/6 males were subjected to IMQ-treatment. (a) Skinfold thickness was measured at the days indicated using a caliper. The mean SEM is shown. n = 3–10 mice in each group. *****, P < 0.00001; **, P < 0.01; by two-way ANOVA followed by Bonferroni post hoc test. (b) Skin was harvested and analysed using histology. Results are rep- resentative of at least three independent experiments. (c) Skin was harvested and subjected to flow cytometry analysis. Total leukocytes were detected using anti CD45 mAbs, whereas neutrophils were detected using anti Ly6G and CD11b mAbs and T cells were detected using anti-CD3 mAbs. The mean of n = 7–10 mice SD is shown. *P < 0.05 by t-test.
    Figure Legend Snippet: Figure 3 Secretory leukocyte protease inhibitor deficiency does not affect psoriatic skin thickness and has only a marginal effect on skin inflammation in experimental psoriasis. WT and SLPI KO C57BL/6 males were subjected to IMQ-treatment. (a) Skinfold thickness was measured at the days indicated using a caliper. The mean SEM is shown. n = 3–10 mice in each group. *****, P < 0.00001; **, P < 0.01; by two-way ANOVA followed by Bonferroni post hoc test. (b) Skin was harvested and analysed using histology. Results are rep- resentative of at least three independent experiments. (c) Skin was harvested and subjected to flow cytometry analysis. Total leukocytes were detected using anti CD45 mAbs, whereas neutrophils were detected using anti Ly6G and CD11b mAbs and T cells were detected using anti-CD3 mAbs. The mean of n = 7–10 mice SD is shown. *P < 0.05 by t-test.

    Techniques Used: Protease Inhibitor, Cytometry

    Figure 5 A model of SLPI involvement in preventing excessive water loss in a reflex- arc regulated manner.
    Figure Legend Snippet: Figure 5 A model of SLPI involvement in preventing excessive water loss in a reflex- arc regulated manner.

    Techniques Used:

    Related Articles

    Blocking Assay:

    Article Title: Identification of Secretory Leukoprotease Inhibitor As an Endogenous Negative Regulator in Allergic Effector Cells.
    Article Snippet: Cells were fixed in 4% paraformaldehyde in PBS and then treated with permeabilizing buffer (BD Bioscience). .. The cells were blocked with blocking reagent (Toyobo) for 1 h at room temperature, incubated with biotinylated goat anti-mouse SLPI (R&D Systems) in Can get signal solution A (Toyobo) overnight at 4°C, and then incubated with allophycocyanin-labeled streptavidin in Can get signal solution B (Toyobo) for another 1 h at room temperature. .. The specimens were mounted with SlowFade Gold and the nuclei were stained with 4′,6-diamino-2-phenylindole (DAPI; Thermo Fisher Scientific).

    Article Title: Identification of Secretory Leukoprotease Inhibitor As an Endogenous Negative Regulator in Allergic Effector Cells
    Article Snippet: Cells were fixed in 4% paraformaldehyde in PBS and then treated with permeabilizing buffer (BD Bioscience). .. The cells were blocked with blocking reagent (Toyobo) for 1 h at room temperature, incubated with biotinylated goat anti-mouse SLPI (R&D Systems) in Can get signal solution A (Toyobo) overnight at 4°C, and then incubated with allophycocyanin-labeled streptavidin in Can get signal solution B (Toyobo) for another 1 h at room temperature. .. The specimens were mounted with SlowFade Gold and the nuclei were stained with 4′,6-diamino-2-phenylindole (DAPI; Thermo Fisher Scientific).

    Incubation:

    Article Title: Identification of Secretory Leukoprotease Inhibitor As an Endogenous Negative Regulator in Allergic Effector Cells.
    Article Snippet: Cells were fixed in 4% paraformaldehyde in PBS and then treated with permeabilizing buffer (BD Bioscience). .. The cells were blocked with blocking reagent (Toyobo) for 1 h at room temperature, incubated with biotinylated goat anti-mouse SLPI (R&D Systems) in Can get signal solution A (Toyobo) overnight at 4°C, and then incubated with allophycocyanin-labeled streptavidin in Can get signal solution B (Toyobo) for another 1 h at room temperature. .. The specimens were mounted with SlowFade Gold and the nuclei were stained with 4′,6-diamino-2-phenylindole (DAPI; Thermo Fisher Scientific).

    Article Title: Identification of Secretory Leukoprotease Inhibitor As an Endogenous Negative Regulator in Allergic Effector Cells
    Article Snippet: Cells were fixed in 4% paraformaldehyde in PBS and then treated with permeabilizing buffer (BD Bioscience). .. The cells were blocked with blocking reagent (Toyobo) for 1 h at room temperature, incubated with biotinylated goat anti-mouse SLPI (R&D Systems) in Can get signal solution A (Toyobo) overnight at 4°C, and then incubated with allophycocyanin-labeled streptavidin in Can get signal solution B (Toyobo) for another 1 h at room temperature. .. The specimens were mounted with SlowFade Gold and the nuclei were stained with 4′,6-diamino-2-phenylindole (DAPI; Thermo Fisher Scientific).

    Negative Control:

    Article Title: Secretory leukocyte protease inhibitor regulates nerve reflex-mediated skin barrier function in psoriasis.
    Article Snippet: .. See the T erm s and C onditions (https://onlinelibrary.w iley.com /term s-and-conditions) on W iley O nline L ibrary for rules of use; O A articles are governed by the applicable C reative C om m ons L icense from WT mice and SLPI KO mice as a negative control were stained with biotinylated goat anti-mouse SLPI (R&D Systems) followed by streptavidin conjugated to APC (eBioscience, San Diego, CA, USA). .. The sections were counterstained with Hoechst dye 33258 (Life Technologies, Carlsbad, CA, USA).

    Staining:

    Article Title: Secretory leukocyte protease inhibitor regulates nerve reflex-mediated skin barrier function in psoriasis.
    Article Snippet: .. See the T erm s and C onditions (https://onlinelibrary.w iley.com /term s-and-conditions) on W iley O nline L ibrary for rules of use; O A articles are governed by the applicable C reative C om m ons L icense from WT mice and SLPI KO mice as a negative control were stained with biotinylated goat anti-mouse SLPI (R&D Systems) followed by streptavidin conjugated to APC (eBioscience, San Diego, CA, USA). .. The sections were counterstained with Hoechst dye 33258 (Life Technologies, Carlsbad, CA, USA).



    Similar Products

    biotinylated goat anti mouse slpi  (R&D Systems)
    94
    R&D Systems biotinylated goat anti mouse slpi
    Figure 1 Secretory leukocyte protease inhibitor expression increases in lesional skin of psoriasis patients and in an experimental model of psoriasis. (a) Fluorescence microscopy images of human skin from the donors indicated. Overlay images from 2 healthy and 2 psoriatic donors are shown. Data are representative for at least 4 donors in each group. (b) <t>Slpi</t> gene expression changes during IMQ and Vaseline treatment in C57BL/6 mice. Control = non-treated mice. The data are shown as mean SD from three independent experiments. Dots indicate individual mice. *, P < 0.05; **, P < 0.01; *****, P < 0.00001; ******, P < 0.000001; by Kruskal–Wallis test with multiple com- parisons. (c) Representative images of SLPI protein expression in mouse skin during IMQ treatment. Skin sections were stained for SLPI (green) and DNA (blue). Data are from one experiment and are representative of at least five experiments. Image from SLPI KO mouse is shown as a negative control. Arrowheads in A & C point to SLPI-stained epidermis. Scale bar = 50 lm.
    Biotinylated Goat Anti Mouse Slpi, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/biotinylated+goat+anti+mouse+slpi/Mouse+SLPI+Biotinylated+Antibody/pm35279880-68-53-57
    Average 94 stars, based on 1 article reviews
    biotinylated goat anti mouse slpi - by Bioz Stars, 2026-09
    94/100 stars
    		  Buy from Supplier
    biotinylated goat  (R&D Systems)
    94
    R&D Systems biotinylated goat
    Figure 1 Secretory leukocyte protease inhibitor expression increases in lesional skin of psoriasis patients and in an experimental model of psoriasis. (a) Fluorescence microscopy images of human skin from the donors indicated. Overlay images from 2 healthy and 2 psoriatic donors are shown. Data are representative for at least 4 donors in each group. (b) <t>Slpi</t> gene expression changes during IMQ and Vaseline treatment in C57BL/6 mice. Control = non-treated mice. The data are shown as mean SD from three independent experiments. Dots indicate individual mice. *, P < 0.05; **, P < 0.01; *****, P < 0.00001; ******, P < 0.000001; by Kruskal–Wallis test with multiple com- parisons. (c) Representative images of SLPI protein expression in mouse skin during IMQ treatment. Skin sections were stained for SLPI (green) and DNA (blue). Data are from one experiment and are representative of at least five experiments. Image from SLPI KO mouse is shown as a negative control. Arrowheads in A & C point to SLPI-stained epidermis. Scale bar = 50 lm.
    Biotinylated Goat, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/biotinylated+goat+anti+mouse+slpi/Mouse+SLPI+Biotinylated+Antibody/pmc05693852-101-61-65
    Average 94 stars, based on 1 article reviews
    biotinylated goat - by Bioz Stars, 2026-09
    94/100 stars
    		  Buy from Supplier

    Image Search Results


    Figure 1 Secretory leukocyte protease inhibitor expression increases in lesional skin of psoriasis patients and in an experimental model of psoriasis. (a) Fluorescence microscopy images of human skin from the donors indicated. Overlay images from 2 healthy and 2 psoriatic donors are shown. Data are representative for at least 4 donors in each group. (b) Slpi gene expression changes during IMQ and Vaseline treatment in C57BL/6 mice. Control = non-treated mice. The data are shown as mean SD from three independent experiments. Dots indicate individual mice. *, P < 0.05; **, P < 0.01; *****, P < 0.00001; ******, P < 0.000001; by Kruskal–Wallis test with multiple com- parisons. (c) Representative images of SLPI protein expression in mouse skin during IMQ treatment. Skin sections were stained for SLPI (green) and DNA (blue). Data are from one experiment and are representative of at least five experiments. Image from SLPI KO mouse is shown as a negative control. Arrowheads in A & C point to SLPI-stained epidermis. Scale bar = 50 lm.

    Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

    Article Title: Secretory leukocyte protease inhibitor regulates nerve reflex-mediated skin barrier function in psoriasis.

    doi: 10.1111/jdv.18065

    Figure Lengend Snippet: Figure 1 Secretory leukocyte protease inhibitor expression increases in lesional skin of psoriasis patients and in an experimental model of psoriasis. (a) Fluorescence microscopy images of human skin from the donors indicated. Overlay images from 2 healthy and 2 psoriatic donors are shown. Data are representative for at least 4 donors in each group. (b) Slpi gene expression changes during IMQ and Vaseline treatment in C57BL/6 mice. Control = non-treated mice. The data are shown as mean SD from three independent experiments. Dots indicate individual mice. *, P < 0.05; **, P < 0.01; *****, P < 0.00001; ******, P < 0.000001; by Kruskal–Wallis test with multiple com- parisons. (c) Representative images of SLPI protein expression in mouse skin during IMQ treatment. Skin sections were stained for SLPI (green) and DNA (blue). Data are from one experiment and are representative of at least five experiments. Image from SLPI KO mouse is shown as a negative control. Arrowheads in A & C point to SLPI-stained epidermis. Scale bar = 50 lm.

    Article Snippet: See the T erm s and C onditions (https://onlinelibrary.w iley.com /term s-and-conditions) on W iley O nline L ibrary for rules of use; O A articles are governed by the applicable C reative C om m ons L icense from WT mice and SLPI KO mice as a negative control were stained with biotinylated goat anti-mouse SLPI (R&D Systems) followed by streptavidin conjugated to APC (eBioscience, San Diego, CA, USA).

    Techniques: Protease Inhibitor, Expressing, Fluorescence, Microscopy, Gene Expression, Control, Staining, Negative Control

    Figure 2 Secretory leukocyte protease inhibitor affects size of skin lesions and skin barrier function beyond the IMQ-challenged site. The mice indicated were subjected to IMQ-treatment followed by kinetic assessment of the lesion size and skin erythema. (a) The repre- sentative image of female WT and SLPI KO mice from mixed background C57BL/6 9 129/SvJ is shown with the indicated site of treat- ment. (b) Cumulative data (the mean SEM) showing size of lesion. n = 3–10 mice in each group. (c) Cumulative data (the mean SEM) showing skin erythema. (d) WT and SLPI KO C57BL6 males were subjected to IMQ-treatment followed by TEWL measure- ment at the days indicated at the central and lateral skin. The mean SEM is shown. n = at least 10 mice in each group. (e) WT and SLPI KO C57BL6 males were injected with 0.9% NaCl i.d. at the stimulated site prior to IMQ-treatment. TEWL was then measured at the days indicated at the central and lateral skin. The mean SEM is shown. n = at least 7 mice in each group. (f) The lateral skin of WT mice was harvested at the days indicated and subjected to qPCR analysis for Slpi mRNA levels. The data are shown as mean SD from three independent experiments. Dots indicate individual mice. *, P < 0.05; **, P < 0.01; ***, P < 0.001; by ANCOVA followed by Bonferroni post hoc test.

    Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

    Article Title: Secretory leukocyte protease inhibitor regulates nerve reflex-mediated skin barrier function in psoriasis.

    doi: 10.1111/jdv.18065

    Figure Lengend Snippet: Figure 2 Secretory leukocyte protease inhibitor affects size of skin lesions and skin barrier function beyond the IMQ-challenged site. The mice indicated were subjected to IMQ-treatment followed by kinetic assessment of the lesion size and skin erythema. (a) The repre- sentative image of female WT and SLPI KO mice from mixed background C57BL/6 9 129/SvJ is shown with the indicated site of treat- ment. (b) Cumulative data (the mean SEM) showing size of lesion. n = 3–10 mice in each group. (c) Cumulative data (the mean SEM) showing skin erythema. (d) WT and SLPI KO C57BL6 males were subjected to IMQ-treatment followed by TEWL measure- ment at the days indicated at the central and lateral skin. The mean SEM is shown. n = at least 10 mice in each group. (e) WT and SLPI KO C57BL6 males were injected with 0.9% NaCl i.d. at the stimulated site prior to IMQ-treatment. TEWL was then measured at the days indicated at the central and lateral skin. The mean SEM is shown. n = at least 7 mice in each group. (f) The lateral skin of WT mice was harvested at the days indicated and subjected to qPCR analysis for Slpi mRNA levels. The data are shown as mean SD from three independent experiments. Dots indicate individual mice. *, P < 0.05; **, P < 0.01; ***, P < 0.001; by ANCOVA followed by Bonferroni post hoc test.

    Article Snippet: See the T erm s and C onditions (https://onlinelibrary.w iley.com /term s-and-conditions) on W iley O nline L ibrary for rules of use; O A articles are governed by the applicable C reative C om m ons L icense from WT mice and SLPI KO mice as a negative control were stained with biotinylated goat anti-mouse SLPI (R&D Systems) followed by streptavidin conjugated to APC (eBioscience, San Diego, CA, USA).

    Techniques: Protease Inhibitor, Injection

    Figure 3 Secretory leukocyte protease inhibitor deficiency does not affect psoriatic skin thickness and has only a marginal effect on skin inflammation in experimental psoriasis. WT and SLPI KO C57BL/6 males were subjected to IMQ-treatment. (a) Skinfold thickness was measured at the days indicated using a caliper. The mean SEM is shown. n = 3–10 mice in each group. *****, P < 0.00001; **, P < 0.01; by two-way ANOVA followed by Bonferroni post hoc test. (b) Skin was harvested and analysed using histology. Results are rep- resentative of at least three independent experiments. (c) Skin was harvested and subjected to flow cytometry analysis. Total leukocytes were detected using anti CD45 mAbs, whereas neutrophils were detected using anti Ly6G and CD11b mAbs and T cells were detected using anti-CD3 mAbs. The mean of n = 7–10 mice SD is shown. *P < 0.05 by t-test.

    Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

    Article Title: Secretory leukocyte protease inhibitor regulates nerve reflex-mediated skin barrier function in psoriasis.

    doi: 10.1111/jdv.18065

    Figure Lengend Snippet: Figure 3 Secretory leukocyte protease inhibitor deficiency does not affect psoriatic skin thickness and has only a marginal effect on skin inflammation in experimental psoriasis. WT and SLPI KO C57BL/6 males were subjected to IMQ-treatment. (a) Skinfold thickness was measured at the days indicated using a caliper. The mean SEM is shown. n = 3–10 mice in each group. *****, P < 0.00001; **, P < 0.01; by two-way ANOVA followed by Bonferroni post hoc test. (b) Skin was harvested and analysed using histology. Results are rep- resentative of at least three independent experiments. (c) Skin was harvested and subjected to flow cytometry analysis. Total leukocytes were detected using anti CD45 mAbs, whereas neutrophils were detected using anti Ly6G and CD11b mAbs and T cells were detected using anti-CD3 mAbs. The mean of n = 7–10 mice SD is shown. *P < 0.05 by t-test.

    Article Snippet: See the T erm s and C onditions (https://onlinelibrary.w iley.com /term s-and-conditions) on W iley O nline L ibrary for rules of use; O A articles are governed by the applicable C reative C om m ons L icense from WT mice and SLPI KO mice as a negative control were stained with biotinylated goat anti-mouse SLPI (R&D Systems) followed by streptavidin conjugated to APC (eBioscience, San Diego, CA, USA).

    Techniques: Protease Inhibitor, Cytometry

    Figure 5 A model of SLPI involvement in preventing excessive water loss in a reflex- arc regulated manner.

    Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

    Article Title: Secretory leukocyte protease inhibitor regulates nerve reflex-mediated skin barrier function in psoriasis.

    doi: 10.1111/jdv.18065

    Figure Lengend Snippet: Figure 5 A model of SLPI involvement in preventing excessive water loss in a reflex- arc regulated manner.

    Article Snippet: See the T erm s and C onditions (https://onlinelibrary.w iley.com /term s-and-conditions) on W iley O nline L ibrary for rules of use; O A articles are governed by the applicable C reative C om m ons L icense from WT mice and SLPI KO mice as a negative control were stained with biotinylated goat anti-mouse SLPI (R&D Systems) followed by streptavidin conjugated to APC (eBioscience, San Diego, CA, USA).

    Techniques: